Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sara Bystrup
Observed names:
S. Bystrup,
Sara Kjaergaard Bystrup
Institution:
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
Observed institutions:
Aarhus University Hospital,
Josep Carreras Leukaemia Research Institute,
Institut Català d'Oncologia,
Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
ORCID:
0000-0001-9029-1734
Observed ORCID:
0000-0001-9029-1734
OpenAlex ID:
A5035619929
Tumor-Related Molecular Mechanisms of Oxaliplatin Resistance
2015
·
Eva Martinez-Balibrea
, Anna Martínez-Cardús
, et al.
·
Molecular Cancer Therapeutics
·
357
Curcumin mediates oxaliplatin-acquired resistance reversion in colorectal cancer cell lines through modulation of CXC-Chemokine/NF-κB signalling pathway
2016
·
Vicenç Ruiz de Porras
, Sara Bystrup
, et al.
·
Scientific Reports
·
144
PDF
Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment
2020
·
Vicenç Ruiz de Porras
, Xieng C. Wang
, et al.
·
European Urology
·
53
PDF
PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines
2015
·
Alba Ginés
, Sara Bystrup
, et al.
·
PLoS ONE
·
42
PDF
Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer Patients
2019
·
Vicenç Ruiz de Porras
, Sara Bystrup
, et al.
·
Cancers
·
23
PDF
Isosteviol Has Beneficial Effects on Palmitate-Induced α-Cell Dysfunction and Gene Expression
2012
·
Xiaoping Chen
, Kjeld Hermansen
, et al.
·
PLoS ONE
·
20
PDF
Effects of Whey Proteins on Glucose Metabolism in Normal Wistar Rats and Zucker Diabetic Fatty (ZDF) Rats
2013
·
Soren Gregersen
, Sara Bystrup
, et al.
·
The Review of Diabetic Studies
·
14
PDF
Efficacy of CT-P6 (trastuzumab biosimilar) versus reference trastuzumab in combination with pertuzumab in HER2-positive early-stage breast cancer: Preclinical and real-life clinical data
2022
·
Adrià Bernat-Peguera
, Macedonia Trigueros
, et al.
·
The Breast
·
11
Abstract 5478: Curcumin mediates reversion to oxaliplatin-acquired resistance in colorectal cancer cell lines through modulation of nuclear factor κB (NFκB) and cyclin-dependent kinase 5 (CDK5)
2015
·
Vicenç Ruiz de Porras
, Sara Bystrup
, et al.
·
Cancer Research
·
3
Abstract A003: Mapping the tumor microenvironment: Spatial Transcriptomic insights into ovarian cancer progression and resistance
2025
·
Kathleen Imbach
, Sergi García
, et al.
·
Cancer Research
·
1
Convergent stromal and immune remodeling defines spatial tumor dynamics in PARP inhibitor–resistant high-grade serous ovarian cancer
2026
·
Kathleen Jane Imbach
, Sergi Cervilla Garcia
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract B083: Single-cell and spatial transcriptomic characterization of treatment resistance and immune dynamics in high-grade serous ovarian cancer
2024
·
Kathleen J. Imbach
, Vikram Naganathan
, et al.
·
Cancer Research
PO-447 CDK5 as a prognostic and predictive factor in colorectal cancer patients
2018
·
S. Cabrero
, S. Bystrup
, et al.
·
ESMO Open
Expression patterns and prognostic value of Cyclin-dependent kinase 5 (Cdk5) in colorectal tumours
2016
·
V. Ruiz de Porras
, S. Cabrero-De las Heras
, et al.
·
European Journal of Cancer
Patients (p) with advanced melanoma receiving rescue surgery (RS), BRAF inhibitors (BRAFi), immunotherapy (IT) or chemotherapy (CT) in an off-protocol, routine clinical setting.
2014
·
Jose Luis Cuadra-Urteaga
, Jose Luis Manzano
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
15
Citation count:
668
H-index:
8
I10-index:
8
Year
Topic
Type